Additionally, Kalaitzidis found that increasing PTH levels measured on a continuous model were not associated with moderate or severe cognitive impairment as measured by the IADL (OR = 1.01, 95% CI: 0.99–1.05). The gene discussed is PTH; the disease is Cognitive impairment.